Ozack ApS
Ozack ApS is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Phase 2, Randomized, Double-blind, Placebo-controlled Crossover Study Evaluating the Efficacy and Safety of LTG-321 in Patients with Osteoarthritis of the Knee
Sponsor Latigo Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Randomized Double-Blind Placebo-Controlled Cross-Over Trial of the Safety, Tolerability, and Efficacy of PN6047 HCl in Peripheral Neuropathic Pain Characterized by Mechanical Allodynia
Sponsor Pharmnovo AB
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A phase 2 randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of topical AT-004 1% in the participants with acne vulgaris.
Sponsor Arctic Therapeutics hf.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Randomized, Double-blind, Placebo-controlled Crossover Study Evaluating the Efficacy and Safety of LTG-001 in Patients with Osteoarthritis of the Knee
Sponsor Latigo Biotherapeutics Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Ozack ApS?
The 2026-10-09 snapshot links Ozack ApS to 4 distinct CTIS trials. Recorded services include Regulatory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Ozack ApS?
The most frequently recorded therapeutic areas are Pain Medicine, Musculoskeletal, Neurology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Ozack ApS conducted?
The linked trials record locations in 4 countries, including Denmark, Czechia, Spain, Poland. These are trial locations, not confirmed office locations or countries where Ozack ApS delivered services.
What can this page tell me about Ozack ApS's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Ozack ApS. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Ozack ApS